I

Isomorphic Labs

AI-powered drug discovery and development

Research Leader / Senior Scientist - Computational Drug Design

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCambridge, MA, USANo salary listed

About the Job

Requirements

  • A PhD in Computational Chemistry or a related scientific field, or equivalent industrial experience.
  • At least 8 years of professional experience for Research Leader roles or 5 years for Senior Scientist roles in a Computational Drug Design role within biotech, pharma, or a contract research organization setting.
  • A proven track record of project leadership or leading computational chemistry efforts on drug discovery programs, with significant contributions to project progression, ideally from hit identification through lead optimisation or candidate nomination.
  • Expertise in writing and implementing Python scripts for analysis and tool development, and/or using pipelining tools to support cheminformatics and design workflows.
  • For a people or program management position, experience leading a high-performing scientific team and mentoring and empowering team members.
  • A strong track record of scientific achievements evidenced by publications, patents, and presentations.
  • Excellent written and verbal communication and interpersonal skills to work effectively in a cross-functional, collaborative team environment.
  • A track record of strategic thinking and creative problem solving, with adaptability and eagerness to learn new concepts and techniques.

Responsibilities

  • Apply AI-first approaches to provide technical and strategic direction and execute drug design programs, taking ownership as either an overall Program Lead or Computational Chemistry Lead.
  • Collaborate cross-functionally to support data-driven delivery of high-quality scientific solutions to complex technical problems.
  • Establish principles for embedding cutting-edge artificial intelligence and machine learning into modern computational chemistry workflows, ensuring integration across machine learning, Biology, and Chemistry teams.
  • Provide strategic input and technical direction to machine learning platform teams.
  • For Program Leadership, champion the drug discovery pipeline, oversee external collaborations with contract research organisations, and lead programs to meet critical go/no-go milestones.
  • Prepare detailed scientific proposals and reports to support new and ongoing programs.
  • For roles with people-management responsibilities, line manage and mentor a team of 2–3 Computational Chemists, supporting their scientific growth and career development.

Desired Qualifications

  • Prior experience leveraging machine learning and generative artificial intelligence methods for hit finding, such as ultra-large virtual screening and active learning, and for molecular design and lead optimisation, such as REINVENT, cofolding, and AI-powered ligand/pose scoring methods.
  • Knowledge of other drug discovery approaches, including fragment-based drug design, and alternative modalities such as PROTACs, molecular glues, protein–protein interaction inhibitors or stabilisers, and peptides.
  • Understanding of drug metabolism and pharmacokinetics principles, including ADME and DMPK.
  • Fluency in Python and ability to write code for new tools.
  • Track record of authorship of relevant scientific manuscripts and/or inventorship of composition-of-matter patents.
  • Experience working with or managing activities at contract research organisations.

About the Company

Isomorphic Labs

AI-powered drug discovery and development

Isomorphic Labs uses artificial intelligence to speed up drug discovery and development. It applies machine learning and computational methods—building predictive and generative models—to accelerate how drugs are designed and how medical research is conducted. The company differentiates itself by combining the AI breakthroughs from Google DeepMind with Alphabet backing, enabling fast experimentation and scaling across biology while maintaining startup-style agility. Its goal is to bring safer, more effective therapies to market more quickly by advancing AI-driven medicine using deep learning, reinforcement learning, and other advanced techniques.

Company size
201-500
Company stage
Series C
Total funding
$7.7B
Headquarters
London, United Kingdom
Founded
2021

Recently Posted Jobs

Explore more opportunities at Isomorphic Labs

See more jobs